- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Europe
- Report
- February 2024
- 78 Pages
Global
From €3500EUR$4,266USD£3,163GBP
- Report
- February 2024
- 78 Pages
Global
From €3500EUR$4,266USD£3,163GBP
- Report
- October 2023
- 80 Pages
Russia
From €1318EUR$1,500USD£1,151GBP
- Report
- October 2023
- 80 Pages
Poland
From €1318EUR$1,500USD£1,151GBP
- Report
- November 2025
- 132 Pages
Global
From €835EUR$950USD£729GBP
- Report
- April 2024
- 132 Pages
Global
From €835EUR$950USD£729GBP
From €113EUR$129USD£99GBP
-
Journal - December 2025
- 46 Pages
Global
From €374EUR$425USD£326GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- April 2024
- 132 Pages
Global
From €835EUR$950USD£729GBP
- Book
- August 2018
- 197 Pages
- Book
- June 2002
- 356 Pages
Europe
- Training
- 90 Minutes
Global
- Report
- November 2021
- 213 Pages
Global
From €2637EUR$3,000USD£2,302GBP

The Pharmacovigilance market is a subset of the Healthcare Services industry, focusing on the monitoring and assessment of the safety of pharmaceutical products. It involves the collection, analysis, and reporting of adverse events related to the use of drugs, as well as the identification of potential risks associated with their use. Pharmacovigilance activities are conducted by pharmaceutical companies, regulatory authorities, and healthcare professionals.
Pharmacovigilance activities are essential for the safe and effective use of drugs, as they help to identify potential risks and ensure that the benefits of the drug outweigh the risks. Pharmacovigilance also helps to ensure that the drug is used appropriately and that any adverse events are reported and addressed.
Some companies in the Pharmacovigilance market include Parexel, Quintiles, Covance, PRA Health Sciences, and ICON. Show Less Read more